Mifepristone is currently licensed in Ireland for use of abortions up to 12 weeks since it was legalised in 2018. Mifepristone is not available in Poland, where abortion is highly restricted.Mifepristone 200 mg tablets (Mifegyne, Mifepristone Linepharma, Medabon) have marketing authorizations in the European Economic Area from the European Medicines Agency (EMA) for:
Early first trimester medication abortion when followed by a prostaglandin analog (misoprostol or gemeprost) through 63 days gestational age
Second trimester medication abortion when followed by a prostaglandin analog
Cervical softening and dilation prior to first trimester surgical abortion
Induction of labor after fetal death in utero when prostaglandin analogs and oxytocin are contraindicated

Other countries
Mifepristone was banned in Australia in 1996. In late 2005, a private members bill was introduced to the Australian Senate to lift the ban and transfer the power of approval to the Therapeutic Goods Administration (TGA). The move caused much debate in the Australian media and among politicians. The bill passed the Senate on 10 February 2006, and mifepristone is now legal in Australia. It is provided regularly at several specialized abortion clinics per state. Mifepristone 200 mg tablets have marketing authorizations in Australia from the TGA for early first trimester medication abortion when followed by the prostaglandin analog misoprostol through 63 days gestational age and second trimester medication abortion when followed by a prostaglandin analog.In New Zealand, pro-abortion rights doctors established an import company, Istar, and submitted a request for approval to Medsafe, the New Zealand pharmaceutical regulatory agency.
IGF-1 is responsible for most of the symptoms of acromegaly, and the normalization of its levels can control the symptoms.Long-term treatment studies with pegvisomant as a monotherapy have shown it to be safe, and effective. Research
Some studies show the potential of using pegvisomant as an anti-tumor treatment for certain types of cancers. References
External links
"Pegvisomant". Drug Information Portal. U.S. National Library of Medicine.